PHARMACEUTICAL RESEARCH IN MOLECULAR ONCOLOGY

被引：116
作者：
GIBBS, JB
OLIFF, A
机构：
[1] Department of Cancer Research Merck Research Laboratories West Point
来源：
CELL | 1994年 / 79卷 / 02期
关键词：
D O I：
10.1016/0092-8674(94)90189-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：193 / 198
页数：6
相关论文
共 40 条
[1]   ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX [J].
AMATI, B ;
BROOKS, MW ;
LEVY, N ;
LITTLEWOOD, TD ;
EVAN, GI ;
LAND, H .
CELL, 1993, 72 (02) :233-245
[2]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[3]   4,5-DIANILINOPHTHALIMIDE - A PROTEIN-TYROSINE KINASE INHIBITOR WITH SELECTIVITY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY AND POTENT IN-VIVO ANTITUMOR-ACTIVITY [J].
BUCHDUNGER, E ;
TRINKS, U ;
METT, H ;
REGENASS, U ;
MULLER, M ;
MEYER, T ;
MCGLYNN, E ;
PINNA, LA ;
TRAXLER, P ;
LYDON, NB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2334-2338
[4]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[5]  
CREEKMORE S, 1992, P AN M AM SOC CLIN, V11, P345
[6]   GENE-THERAPY FOR CANCER [J].
CULVER, KW ;
BLAESE, RM .
TRENDS IN GENETICS, 1994, 10 (05) :174-178
[7]   FOS AND JUN - THE AP-1 CONNECTION [J].
CURRAN, T ;
FRANZA, BR .
CELL, 1988, 55 (03) :395-397
[8]  
DEVITA VT, 1993, CANCER PRINCIPLES PR
[9]   THE PATHWAY TO SIGNAL ACHIEVEMENT [J].
EGAN, SE ;
WEINBERG, RA .
NATURE, 1993, 365 (6449) :781-783
[10]   RECOGNITION BY MAX OF ITS COGNATE DNA THROUGH A DIMERIC B/HLH/Z DOMAIN [J].
FERREDAMARE, AR ;
PRENDERGAST, GC ;
ZIFF, EB ;
BURLEY, SK .
NATURE, 1993, 363 (6424) :38-45
1234